These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1155 related articles for article (PubMed ID: 26419471)

  • 1. Effect of osteoporosis medications on fracture healing.
    Hegde V; Jo JE; Andreopoulou P; Lane JM
    Osteoporos Int; 2016 Mar; 27(3):861-871. PubMed ID: 26419471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-osteoporosis therapy and fracture healing.
    Larsson S; Fazzalari NL
    Arch Orthop Trauma Surg; 2014 Feb; 134(2):291-7. PubMed ID: 22684739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Morphological analysis of bone dynamics and metabolic bone disease. Histological findings in animal fracture model--effects of osteoporosis treatment drugs on fracture healing process].
    Mashiba T
    Clin Calcium; 2011 Apr; 21(4):551-8. PubMed ID: 21447922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strontium ranelate as an adjuvant for fracture healing: clinical, radiological, and ultrasound findings in a randomized controlled study on wrist fractures.
    Scaglione M; Fabbri L; Casella F; Guido G
    Osteoporos Int; 2016 Jan; 27(1):211-8. PubMed ID: 26294293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic administration of pharmacological agents and bone repair: what can we expect.
    Bukata SV
    Injury; 2011 Jun; 42(6):605-8. PubMed ID: 21507402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications for fracture healing of current and new osteoporosis treatments: an ESCEO consensus paper.
    Goldhahn J; Féron JM; Kanis J; Papapoulos S; Reginster JY; Rizzoli R; Dere W; Mitlak B; Tsouderos Y; Boonen S
    Calcif Tissue Int; 2012 May; 90(5):343-53. PubMed ID: 22451221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zoledronic acid suppresses callus remodeling but enhances callus strength in an osteoporotic rat model of fracture healing.
    Hao Y; Wang X; Wang L; Lu Y; Mao Z; Ge S; Dai K
    Bone; 2015 Dec; 81():702-711. PubMed ID: 26434668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biology of fracture healing in osteoporosis and in the presence of anti-osteoporotic drugs.
    Hak DJ
    Injury; 2018 Aug; 49(8):1461-1465. PubMed ID: 29709376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strontium ranelate enhances callus strength more than PTH 1-34 in an osteoporotic rat model of fracture healing.
    Habermann B; Kafchitsas K; Olender G; Augat P; Kurth A
    Calcif Tissue Int; 2010 Jan; 86(1):82-9. PubMed ID: 19960189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of teriparatide in osteoporotic fracture patients.
    Collinge C; Favela J
    Injury; 2016 Jan; 47 Suppl 1():S36-8. PubMed ID: 26768289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healing of the bone with anti-fracture drugs.
    Vannucci L; Brandi ML
    Expert Opin Pharmacother; 2016 Dec; 17(17):2267-2272. PubMed ID: 27673358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How do bisphosphonates affect fracture healing?
    Kates SL; Ackert-Bicknell CL
    Injury; 2016 Jan; 47 Suppl 1(0 1):S65-8. PubMed ID: 26768295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fracture repair: general aspects and influence of osteoporosis and anti-osteoporosis treatment.
    Féron JM; Mauprivez R
    Injury; 2016 Jan; 47 Suppl 1():S10-4. PubMed ID: 26768282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of post-menopausal osteoporosis: beyond bisphosphonates.
    Ishtiaq S; Fogelman I; Hampson G
    J Endocrinol Invest; 2015 Jan; 38(1):13-29. PubMed ID: 25194424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does bisphosphonate-based anti-osteoporosis medication affect osteoporotic spinal fracture healing?
    Ha KY; Park KS; Kim SI; Kim YH
    Osteoporos Int; 2016 Feb; 27(2):483-8. PubMed ID: 26202489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review.
    Gallacher SJ; Dixon T
    Calcif Tissue Int; 2010 Dec; 87(6):469-84. PubMed ID: 20872215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of anti-osteoporosis medications on fracture healing.
    Jørgensen NR; Schwarz P
    Curr Osteoporos Rep; 2011 Sep; 9(3):149-55. PubMed ID: 21698357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of postmenopausal osteoporosis and the prevention of fractures.
    Gambacciani M; Levancini M
    Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.
    McDonald MM; Dulai S; Godfrey C; Amanat N; Sztynda T; Little DG
    Bone; 2008 Oct; 43(4):653-62. PubMed ID: 18582604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Strontium Ranelate on Metaphyseal Bone Healing in Ovariectomized Rats.
    Komrakova M; Weidemann A; Dullin C; Ebert J; Tezval M; Stuermer KM; Sehmisch S
    Calcif Tissue Int; 2015 Oct; 97(4):391-401. PubMed ID: 26084691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.